Advertisement

Multimorbidity and polypharmacy among elderly people followed in general practices in Germany

      Multimorbidity, defined as the presence of two or more chronic conditions, has been a growing health problem globally, especially in recent decades [
      • Salive M.E.
      Multimorbidity in older adults.
      ]. Polypharmacy, which is often defined as the prescription of at least five different drugs, is strongly associated with multimorbidity [
      • Masnoon N.
      • Shakib S.
      • Kalisch-Ellett L.
      • Caughey G.E.
      What is polypharmacy? A systematic review of definitions.
      ].

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Salive M.E.
        Multimorbidity in older adults.
        Epidemiol. Rev. 2013; 35: 75-83https://doi.org/10.1093/epirev/mxs009
        • Masnoon N.
        • Shakib S.
        • Kalisch-Ellett L.
        • Caughey G.E.
        What is polypharmacy? A systematic review of definitions.
        BMC Geriatr. 2017; 17 (PMID: 29017448PMCID: PMC5635569)https://doi.org/10.1186/s12877-017-0621-2
        • Kirchberger I.
        • Meisinger C.
        • Heier M.
        • Zimmermann A.-K.
        • Thorand B.
        • Autenrieth C.S.
        • Peters A.
        • Ladwig K.-H.
        • Döring A.
        Patterns of multimorbidity in the aged population. Results from the KORA-age study.
        PLoS One. 2012; 7 (PMID: 22291986PMCID: PMC3264590)https://doi.org/10.1371/journal.pone.0030556
        • Jacob L.
        • Breuer J.
        • Kostev K.
        Prevalence of chronic diseases among older patients in German general practices.
        GMS Ger Med Sci. 2016; 14 (PMID: 26977142PMCID: PMC4779902)https://doi.org/10.3205/000230
        • Puth M.-T.
        • Weckbecker K.
        • Schmid M.
        • Münster E.
        Prevalence of multimorbidity in Germany: impact of age and educational level in a cross-sectional study on 19,294 adults.
        BMC Public Health. 2017; 17 (PMID: 29047341PMCID: PMC5648462)https://doi.org/10.1186/s12889-017-4833-3
        • Schöttker B.
        • Saum K.-U.
        • Muhlack D.C.
        • Hoppe L.K.
        • Holleczek B.
        • Brenner H.
        Polypharmacy and mortality: new insights from a large cohort of older adults by detection of effect modification by multi-morbidity and comprehensive correction of confounding by indication.
        Eur. J. Clin. Pharmacol. 2017; 73: 1041-1048https://doi.org/10.1007/s00228-017-2266-7
        • Junius-Walker U.
        • Theile G.
        • Hummers-Pradier E.
        Prevalence and predictors of polypharmacy among older primary care patients in Germany.
        Fam. Pract. 2007; 24 (PMID: 17164234): 14-19https://doi.org/10.1093/fampra/cml067
        • Dörks M.
        • Herget-Rosenthal S.
        • Schmiemann G.
        • Hoffmann F.
        Polypharmacy and renal failure in nursing home residents: results of the inappropriate medication in patients with renal insufficiency in nursing homes (IMREN) study.
        Drugs Aging. 2016; 33: 45-51https://doi.org/10.1007/s40266-015-0333-2
        • Dombrowski S.
        • Kostev K.
        Use of electronic medical Records in the Epidemiological Research.
        Cuvillier Verlag, 2017